Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stroke

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    August 2017
  1. BOKMA JP, Zegstroo I, Kuijpers JM, Konings TC, et al
    Factors associated with coronary artery disease and stroke in adults with congenital heart disease.
    Heart. 2017 Aug 28. pii: heartjnl-2017-311620. doi: 10.1136/heartjnl-2017-311620
    PubMed     Text format     Abstract available


  2. LIM WY, Lloyd G, Bhattacharyya S
    Mechanical and surgical bioprosthetic valve thrombosis.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311856. doi: 10.1136/heartjnl-2017-311856.
    PubMed     Text format     Abstract available


    June 2017
  3. ISAEW A, Adderley NJ, Ryan R, Fitzmaurice D, et al
    The treatment of paroxysmal atrial fibrillation in UK primary care.
    Heart. 2017 Jun 1. pii: heartjnl-2016-310927. doi: 10.1136/heartjnl-2016-310927.
    PubMed     Text format     Abstract available


    March 2017
  4. JACKEVICIUS CA, Tsadok MA, Essebag V, Atzema C, et al
    Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation.
    Heart. 2017 Mar 12. pii: heartjnl-2016-310672. doi: 10.1136/heartjnl-2016-310672
    PubMed     Text format     Abstract available


  5. CAVALCANTE R, Sotomi Y, Zeng Y, Lee CW, et al
    Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Heart. 2017;103:428-433.
    PubMed     Text format     Abstract available


    February 2017
  6. LAUW MN, Eikelboom JW, Coppens M, Wallentin L, et al
    Effects of dabigatran according to age in atrial fibrillation.
    Heart. 2017 Feb 17. pii: heartjnl-2016-310358. doi: 10.1136/heartjnl-2016-310358
    PubMed     Text format     Abstract available


    November 2016
  7. YANG F, Hellyer JA, Than C, Ullal AJ, et al
    Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease.
    Heart. 2016 Nov 15. pii: heartjnl-2016-309266. doi: 10.1136/heartjnl-2016-309266
    PubMed     Text format     Abstract available


    October 2016
  8. BAHIT MC, Lopes RD, Wojdyla DM, Held C, et al
    Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
    Heart. 2016 Oct 24. pii: heartjnl-2016-309901. doi: 10.1136/heartjnl-2016-309901
    PubMed     Text format     Abstract available


    September 2016
  9. OU SM, Chen HT, Kuo SC, Chen TJ, et al
    Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
    PubMed     Text format     Abstract available


  10. CAMM AJ, Accetta G, Ambrosio G, Atar D, et al
    Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309832. doi: 10.1136/heartjnl-2016-309832
    PubMed     Text format     Abstract available


  11. SAHAY S, Nombela-Franco L, Rodes-Cabau J, Jimenez-Quevedo P, et al
    Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Heart. 2016 Sep 1. pii: heartjnl-2016-309782. doi: 10.1136/heartjnl-2016-309782.
    PubMed     Text format     Abstract available


    August 2016
  12. ALLAN V, Banerjee A, Shah AD, Patel R, et al
    Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care.
    Heart. 2016 Aug 31. pii: heartjnl-2016-309910. doi: 10.1136/heartjnl-2016-309910
    PubMed     Text format     Abstract available


  13. PURI R, Byrne J, Muller R, Baumbach H, et al
    Transcatheter aortic valve implantation in patients with small aortic annuli using a 20 mm balloon-expanding valve.
    Heart. 2016 Aug 17. pii: heartjnl-2016-309707. doi: 10.1136/heartjnl-2016-309707
    PubMed     Text format     Abstract available


  14. BERTI S, Pastormerlo LE, Rezzaghi M, Trianni G, et al
    Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation.
    Heart. 2016 Aug 4. pii: heartjnl-2015-309150. doi: 10.1136/heartjnl-2015-309150.
    PubMed     Text format     Abstract available


    June 2016
  15. SENOO K, An Y, Ogawa H, Lane DA, et al
    Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom.
    Heart. 2016 Jun 16. pii: heartjnl-2016-309741. doi: 10.1136/heartjnl-2016-309741
    PubMed     Text format     Abstract available


  16. DHILLON A, Khanna A, Randhawa MS, Cywinski J, et al
    Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309442. doi: 10.1136/heartjnl-2016-309442
    PubMed     Text format     Abstract available


    March 2016
  17. ASSRESS KN, Marciniak M, Marciniak A, Rajani R, et al
    Development of the atrial septum.
    Heart. 2016;102:481-2.
    PubMed     Text format    


  18. ANDERSON RH
    Development of the atrial septum.
    Heart. 2016;102:481.
    PubMed     Text format    


    February 2016
  19. BATRA G, Svennblad B, Held C, Jernberg T, et al
    All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome.
    Heart. 2016 Feb 29. pii: heartjnl-2015-308678. doi: 10.1136/heartjnl-2015-308678
    PubMed     Text format     Abstract available


  20. BREITHARDT G, Baumgartner H, Berkowitz SD, Hellkamp AS, et al
    Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban.
    Heart. 2016 Feb 17. pii: heartjnl-2015-308120. doi: 10.1136/heartjnl-2015-308120
    PubMed     Text format     Abstract available


    January 2016
  21. JAWAD-UL-QAMAR M, Kirchhof P
    Almanac 2015: atrial fibrillation research in Heart.
    Heart. 2016 Jan 20. pii: heartjnl-2015-307809. doi: 10.1136/heartjnl-2015-307809
    PubMed     Text format     Abstract available


  22. VALEUR N, Merie C, Hansen ML, Torp-Pedersen C, et al
    Risk of death and stroke associated with anticoagulation therapy after mitral valve repair.
    Heart. 2016 Jan 4. pii: heartjnl-2015-308272. doi: 10.1136/heartjnl-2015-308272.
    PubMed     Text format     Abstract available


    December 2015
  23. ASRRESS KN, Marciniak M, Marciniak A, Rajani R, et al
    Patent foramen ovale: the current state of play.
    Heart. 2015;101:1916-25.
    PubMed     Text format    


    November 2015
  24. ADAMSON PD, Dweck MR, Newby DE
    The vulnerable atherosclerotic plaque: in vivo identification and potential therapeutic avenues.
    Heart. 2015;101:1755-66.
    PubMed     Text format    


  25. MAHTANI KR, Nunan D, Heneghan C
    Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin.
    Heart. 2015;101:1689-90.
    PubMed     Text format    


    October 2015
  26. ABDEL-QADIR H, Yan AT, Tan M, Borgia F, et al
    Consistency of benefit from an early invasive strategy after fibrinolysis: a patient-level meta-analysis.
    Heart. 2015;101:1554-61.
    PubMed     Text format     Abstract available


    September 2015
  27. AL-ANSARI Y, Otalvaro L, Damluji AA
    Ischaemic stroke after ST-elevation myocardial infarction.
    Heart. 2015 Sep 10. pii: heartjnl-2015-308029. doi: 10.1136/heartjnl-2015-308029
    PubMed     Text format    


    August 2015
  28. KWOK CS, Boekholdt SM, Lentjes MA, Loke YK, et al
    Habitual chocolate consumption and risk of cardiovascular disease among healthy men and women.
    Heart. 2015;101:1279-87.
    PubMed     Text format     Abstract available


    June 2015
  29. CALDEIRA D, Rodrigues FB, Barra M, Santos AT, et al
    Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.
    Heart. 2015 Jun 2. pii: heartjnl-2015-307489. doi: 10.1136/heartjnl-2015-307489.
    PubMed     Text format     Abstract available


  30. OTTO CM
    Heartbeat: Focus on atrial fibrillation.
    Heart. 2015;101:823-5.
    PubMed     Text format    


  31. MINGUEZ JR, Asensio JM, Gragera JE, Costa M, et al
    Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure.
    Heart. 2015;101:877-83.
    PubMed     Text format     Abstract available


  32. ALLI O, Holmes D Jr
    Left atrial appendage occlusion.
    Heart. 2015;101:834-41.
    PubMed     Text format     Abstract available


    May 2015
  33. HASSELL ME, Hildick-Smith D, Durand E, Kikkert WJ, et al
    Antiplatelet therapy following transcatheter aortic valve implantation.
    Heart. 2015 May 6. pii: heartjnl-2014-307053. doi: 10.1136/heartjnl-2014-307053.
    PubMed     Text format     Abstract available


  34. KEACH JW, Bradley SM, Turakhia MP, Maddox TM, et al
    Early detection of occult atrial fibrillation and stroke prevention.
    Heart. 2015 May 2. pii: heartjnl-2015-307588. doi: 10.1136/heartjnl-2015-307588.
    PubMed     Text format     Abstract available


  35. ELBOUDWAREJ O, Wei J, Siegel R
    Diagnosis of an aortic valvular lesion. Non-bacterial thrombotic endocarditis (NBTE).
    Heart. 2015;101:719.
    PubMed     Text format    


    April 2015
  36. STAMBOUL K, Zeller M, Fauchier L, Gudjoncik A, et al
    Prognosis of silent atrial fibrillation after acute myocardial infarction at 1-year follow-up.
    Heart. 2015 Apr 22. pii: heartjnl-2014-307253. doi: 10.1136/heartjnl-2014-307253
    PubMed     Text format     Abstract available


  37. BERTI D, Moors E, Moons P, Heidbuchel H, et al
    Prevalence and antithrombotic management of atrial fibrillation in hospitalised patients.
    Heart. 2015 Apr 14. pii: heartjnl-2014-307059. doi: 10.1136/heartjnl-2014-307059
    PubMed     Text format     Abstract available


    March 2015
  38. DHANA K, Ikram MA, Hofman A, Franco OH, et al
    Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model.
    Heart. 2015;101:377-83.
    PubMed     Text format     Abstract available


  39. FERRARIO MM, Veronesi G
    Aspirin use in women for primary prevention.
    Heart. 2015;101:335-6.
    PubMed     Text format    


    February 2015
  40. YAP SC
    Atrial fibrillation and stroke after atrial septal defect closure. Is earlier closure warranted?
    Heart. 2015 Feb 23. pii: heartjnl-2015-307554. doi: 10.1136/heartjnl-2015-307554
    PubMed     Text format    


  41. NYBOE C, Olsen MS, Nielsen-Kudsk JE, Hjortdal VE, et al
    Atrial fibrillation and stroke in adult patients with atrial septal defect and the long-term effect of closure.
    Heart. 2015 Feb 17. pii: heartjnl-2014-306552. doi: 10.1136/heartjnl-2014-306552
    PubMed     Text format     Abstract available


  42. MOLLMANN H, Kim WK, Kempfert J, Walther T, et al
    Complications of transcatheter aortic valve implantation (TAVI): how to avoid and treat them.
    Heart. 2015 Feb 6. pii: heartjnl-2013-304708. doi: 10.1136/heartjnl-2013-304708.
    PubMed     Text format    


  43. ROY A, Roe MT, Neely ML, Cyr DD, et al
    Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome.
    Heart. 2015;101:279-86.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: